A leading private equity player

The power of and

Companies must face multiple challenges to innovate, grow and adapt to a rapidly changing environment. It has been Andera Partners’ mission for over 20 years to help companies and their management achieve strong and sustainable growth. Our conviction, at the heart of our commitment, our partnership and our way to work with entrepreneurs, is that to grow and develop, it is essential to have the right partners and enjoy working together. The Power of And thus becomes Andera Partners’ signature that relays our conviction.

Our commitments Our investments

3,6 billion under management

291 companies supported in over 20 years

93 professionals

Our Activities

Andera Partners is an asset management firm specialising in Private Equity. We draw on our expertise in various areas to provide a range of well-defined investment strategies. Our goal is to provide bespoke solutions to meet the challenges faced by leaders and their development models.

Our activities

Our Latest News

Below you will find all the latest news on Andera Partners, its teams and its investments.

20.07.2022 - andera Life Sciences - Press releases

Medical Microinstruments Secures $75M to Advance Robotic Microsurgery

Combined Shape

13.07.2022 - andera Life Sciences - Press releases

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M

Combined Shape

07.07.2022 - andera Life Sciences - Press releases

Andera Partners strengthens its Life Sciences team with a new partner

Combined Shape

04.07.2022 - Andera Partners - Publications

Annual CSR Report 2021 / Rapport Annuel RSE 2021

Combined Shape

13.06.2022 - andera Life Sciences - Press releases

ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Validation of…

Combined Shape

08.06.2022 - andera Life Sciences - Press releases

Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to…

Combined Shape

17.05.2022 - andera Life Sciences - Press releases

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replace…

Combined Shape

13.05.2022 - andera MidCap - Press releases

Andera Partners announces the intermediate closing of its new fund Andera MidCap 5 at €450m

Combined Shape

11.05.2022 - andera MidCap - Press releases

HR Path receives €225 million in Financing

Combined Shape

03.05.2022 - andera Life Sciences - Press releases

Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development o…

Combined Shape

27.04.2022 - andera Expansion/Croissance - Press releases

Andera Partners to support ElaN Group, the leading technology platform for translation services in t…

Combined Shape

26.04.2022 - andera Life Sciences - Press releases

Successful first in human implantation of Topaz Tricuspid Heart Valve Replacement System

Combined Shape

07.04.2022 - andera Life Sciences - Press releases

Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer

Combined Shape

01.04.2022 - andera Co-Invest - Press releases

Andera Partners and Compagnie Lebon launch a co-investment activity

Combined Shape

31.03.2022 - Andera Partners - Press releases

Andera Partners announces two promotions to Partner and several appointments to strengthen its teams

Combined Shape
Our Latest News